2023
DOI: 10.1016/j.hjc.2023.02.004
|View full text |Cite
|
Sign up to set email alerts
|

Prevalence, characteristics, and natural history of apical phenotype in a large cohort of patients with hypertrophic cardiomyopathy

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(2 citation statements)
references
References 45 publications
0
2
0
Order By: Relevance
“…At mid-term follow-up, we observed a progressive decline in LV mechanics in the ApHCM-Pure group, although a greater degree of impairment persisted in ApHCM-Mixed patients upon comparison. This adds to the characterization of ApHCM as a progressive cardiomyopathy, and, with the aforementioned discussion, suggests that ApHCM-Mixed represents a distinct subtype with more advanced ventricular dysfunction and concerns regarding observed all-cause mortality, which requires further investigation [ 7 , 8 , 11 , 12 , 13 ]. Previously identified risk factors for poor LV GLS in ApHCM include atrial fibrillation, mitral annular e’ velocity, and glomerular filtration rate, and RV hypertrophy for RV GLS [ 8 , 27 ].…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…At mid-term follow-up, we observed a progressive decline in LV mechanics in the ApHCM-Pure group, although a greater degree of impairment persisted in ApHCM-Mixed patients upon comparison. This adds to the characterization of ApHCM as a progressive cardiomyopathy, and, with the aforementioned discussion, suggests that ApHCM-Mixed represents a distinct subtype with more advanced ventricular dysfunction and concerns regarding observed all-cause mortality, which requires further investigation [ 7 , 8 , 11 , 12 , 13 ]. Previously identified risk factors for poor LV GLS in ApHCM include atrial fibrillation, mitral annular e’ velocity, and glomerular filtration rate, and RV hypertrophy for RV GLS [ 8 , 27 ].…”
Section: Discussionmentioning
confidence: 99%
“…This phenotypic distinction is salient given the importance of the interventricular septum to bi-ventricular mechanical performance and efficiency [ 9 , 10 ]. Despite the clinical significance of ApHCM within the spectrum of cardiomyopathic disorders, there are limited data comparing ApHCM-Pure and ApHCM-Mixed [ 11 , 12 , 13 ]. A single study signaled that ApHCM-Mixed may be independently associated with a greater than 3-fold increased risk of cardiovascular morbidity, which was defined as hospitalization for syncope, congestive heart failure, nonfatal arrhythmia, stroke, or myocardial infarction [ 11 ].…”
Section: Introductionmentioning
confidence: 99%